Brian S Henick - Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT226: Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor

Jameel Muzaffar,Kedar Kirtane, Rebecca Redman,Muh-Hwa Yang,Tae Min Kim,Stephen Liu,Ryan Lynch,Julie Brahmer, Patricia LoRusso,Brian Henick,Sung-bae Kim,Yin-Hsun Feng,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Severe scalp ulcerations and granulomata during treatment with amivantamab

Jingjia J. Zhou, Lanyi N. Chen, Thomas Lehan,Benjamin Herzberg,Brian S. Henick, Michael Pitman,Stephanie Gallitano,Catherine A. Shu

CURRENT PROBLEMS IN CANCER: CASE REPORTS (2024): 100273

引用0浏览0引用

Abstract 3634: Copy number alterations in chromosome 19 genes associate with reduced immune infiltrate and adverse outcomes in lung cancer

Brian S. Henick,Yohanna Georgis,Benjamin O. Herzberg, Carla P. Concepcion-Crisol,Alison M. Taylor

Cancer Researchno. 6_Supplement (2024): 3634-3634

引用0浏览0引用

Abstract 1367: PD1 signaling uncovers a pathogenic subset of cytotoxic T cells

Shoiab Bukhari,Shalom Lerrer, Johanna Straube, Robert Winchester,Brian Henick,Matthew Dragovich,Adam Mor

Cancer Researchno. 6_Supplement (2024): 1367-1367

引用0浏览0引用

Abstract CT183: Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132)

Benjamin Izar,Dmitriy Zamarin,David R. Spigel, Christopher J. Hoimes,David F. McDermott,Kartik Sehgal,Yana G. Najjar, Adam J. Schoenfeld,Edward B. Garon,Ryan J. Sullivan,Brian S. Henick,Ticiana A. Leal,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Controlled Chaos: Parsing Acquired Immunoresistance in Lung Cancer

Brian S Henick,Benjamin O Herzberg, Carla P Concepcion-Crisol,Alison M Taylor

Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2302339-JCO2302339, (2024)

引用0浏览0WOS引用

PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis

Johanna Straube,Shoiab Bukhari,Shalom Lerrer,Robert J. Winchester, Yevgeniya Gartshteyn,Brian S. Henick, Matthew A. Dragovich,Adam Mor

Arthritis Research & Therapyno. 1 (2024): 1-14

引用0浏览0WOS引用

Severe scalp ulcerations and granulomata during treatment with amivantamab

Jingjia J Zhou, Lanyi N Chen, Thomas Lehan, Benjamin Herzberg,Brian S Henick,Michael Pitman,Stephanie Gallitano,Catherine A Shu

Current Problems in Cancer: Case Reports (2024): 100273

引用0浏览0引用

Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

Brian S Henick, Xizi Hu,Shoiab M Bukhari, Carly Tymm,Kieran Adam,Shalom Lerrer, Robert J Winchester,Adam Mor

Journal for ImmunoTherapy of Cancerno. 3 (2024)

引用0浏览0引用

Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

Xizi Hu,Shoiab M Bukhari, Carly Tymm,Kieran Adam,Shalom Lerrer,Brian S Henick, Robert J Winchester,Adam Mor

Journal for ImmunoTherapy of Cancerno. 3 (2024): 4028-4028

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn